文献速递肿瘤 PET/CT核素与放射性配体治疗

前列腺癌68Ga-PSMA PET观察者间一致性的系统评价与Meta分析

68Ga-PSMA PET in prostate cancer: a systematic review and meta-analysis of the observer agreement.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2021-11-12

该系统评价与Meta分析纳入12项研究、1585例68Ga-PSMA PET/CT-MR检查、62名独立阅片者,评估前列腺癌患者中观察者间一致性。总体合并观察者间一致性为中等(substantial),前列腺床肿瘤病灶、淋巴结病变、骨转移和软组织转移各组均介于0.6至0.8之间;区域淋巴结病变组一致性最高(0.74),软组织转移组最低(0.65)。结论认为68Ga-PSMA PET/CT-MR在前列腺癌患者整体判读及检测区域性和远处受累方面显示中等观察者间一致性。

要点

  • 纳入12项研究、1585例68Ga-PSMA PET/CT-MR检查、62名独立阅片者。
  • 总体合并观察者间一致性为中等(substantial),各组K值均介于0.6至0.8。
  • 区域淋巴结病变组一致性最高(0.74),软组织转移组最低(0.65)。

核心结论

  • 68Ga-PSMA PET/CT-MR在前列腺癌患者整体判读及检测区域性和远处受累方面显示中等(substantial)观察者间一致性。

研究设计与样本

  • 系统评价与Meta分析,纳入12项研究,共1585例68Ga-PSMA PET/CT-MR检查,由62名独立阅片者判读。
  • 纳入标准包括:提供Kappa(K)作为观察者间一致性检验或计算所需基础数据;提供K置信区间或计算所需原始数据;基于适当使用标准测量K统计量。

主要发现

  • 总体合并观察者间一致性为中等(substantial),所有分析组(前列腺床肿瘤病灶、淋巴结病变、骨转移、软组织转移)K值均介于0.6至0.8之间。
  • 区域淋巴结病变组一致性最高(0.74),软组织转移组最低(0.65)。

关键数值与推荐

  • 区域淋巴结病变组K值为0.74,为各分析组中最高。
  • 软组织转移组K值为0.65,为各分析组中最低。
  • 前列腺床肿瘤病灶、淋巴结病变、骨转移和软组织转移各组K值均介于0.6至0.8之间。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The performance of 68 Ga-PSMA PET/CT-MR has been evaluated in prostate cancer (PCa), showing significant results. However, even a technically accurate imaging procedure requires a high interobserver agreement in its interpretation to implement in patients' management. This study aims to perform a systematic review and meta-analysis on the interobserver variability in 68 Ga-PSMA PET/CT-MR imaging in PCa patients. METHODS: We conducted a systematic review and meta-analysis on the interobserver variability, including studies: (1) providing Kappa (K) as the inter-observer agreement test or the essential data to calculate it, (2) providing the K confidence interval or the essential crude data to calculate it, (3) measuring K statistic based on the appropriate use criteria for the inter-observer agreement. RESULTS: Twelve studies, providing 1585 68 Ga-PSMA PET/CT-MR studies reviewed by 62 independent readers, were included. In general, the pooled inter-observer agreement was interpreted as substantial for all analyzed groups, including tumoral lesions in the prostate bed, lymphadenopathies, bone metastasis, and soft-tissue metastasis (all between 0.6 and 0.8). The regional lymphadenopathy group (0.74) obtained the highest agreement, while the lowest was for soft tissue metastasis (0.65). CONCLUSION: This study showed a substantial interobserver agreement in the overall interpretation and detecting locoregional and distant involvement with 68 Ga-PSMA PET/CT-MR in PCa patients.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Chavoshi M, Mirshahvalad SA, Metser U, et al. 68Ga-PSMA PET in prostate cancer: a systematic review and meta-analysis of the observer agreement. Eur J Nucl Med Mol Imaging. 2021. PMID: 34767046. doi:10.1007/s00259-021-05616-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。